Beyond Surgery: MTF Biologics Invests in Science to Transform Lives

Invigorating its mission to save lives through tissue and organ advancements, MTF Biologics awarded $930,000 in 2023! Six global projects across orthopedics, plastic surgery, and wound care secured funding, showcasing MTF’s unwavering dedication to research breakthroughs.

“These grants directly fuel allograft science progress, aligning with our core mission,” stated Joe Yaccarino, CEO. “We celebrate this year’s recipients and eagerly await their impactful outcomes.”

Since 1987, MTF has proudly invested over $60 million, propelling scientific leaps and improving patient care in diverse fields.

“Our continued grant support aims to accelerate breakthroughs and ultimately improve patient outcomes,” remarked Marc Long, Research & Development EVP. “This year’s range of clinical applications is particularly impressive, offering promising allograft-based solutions.”

2023 Awardees (Junior/Established):

  • Skeletal Muscle Regeneration: Taimoor Qazi (PhD, Purdue), Gianluca Cidonio (PhD, Italy)
  • Cryopreservation of Intact IVDs: Adam Higgins (PhD, Oregon State) (Dr. James R. Neff Excellence Awardee)
  • Rotator Cuff Repair: William Blakeny (MD, Australia)
  • Diabetic Wound Repair: Hongjun Wang (PhD, Stevens Institute)
  • Muscle Loss Recovery: Young Min Ju (PhD, Wake Forest) (Dr. Hans Burchardt Impact Awardee)

“We received exceptional proposals this year, from both within and beyond the US,” said Jeffrey Cartmell, Sr. Director of Grants. “Two grants heading overseas solidify our global impact.”

Letters of Intent for the 2024 program are open until March 15th. Learn more at [].

By nurturing scientific talent and groundbreaking research, MTF Biologics continues to revolutionize allograft science, promising a brighter future for countless individuals worldwide.